Related Experiment Video

Updated: Sep 17, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Hypertriglyceridemia in New-Onset Type 1 Pediatric Diabetes

Colleen A Macke1, Iman Al-Gadi1, Nidhi Bansal1

  • 1Division of Diabetes and Endocrinology, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas, USA.

Pediatric Diabetes
|July 4, 2025
PubMed

Insights

Severe hypertriglyceridemia (HTG) is rare in children with new-onset type 1 diabetes (T1D) but can lead to serious complications like pancreatitis. Early screening and monitoring for HTG are crucial in these patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus

Background:

  • Hypertriglyceridemia (HTG) is common in new-onset diabetes due to insulin deficiency.
  • Severe HTG (TG > 1000 mg/dL) in pediatric patients with new-onset type 1 diabetes (T1D) is rare and poorly characterized.
  • Insulin deficiency impairs triglyceride clearance and promotes lipolysis.

Purpose of the Study:

  • To characterize the incidence and sequelae of severe HTG in pediatric patients with new-onset T1D.
  • To review a single-center experience and literature cases of severe HTG in this population.
  • To discuss potential screening and monitoring strategies.

Main Methods:

  • Retrospective review of a single-center experience (2013-2022).
  • Literature search for previously reported cases of severe HTG in pediatric new-onset T1D.
  • Analysis of patient presentations, TG levels, and associated complications.

Main Results:

  • Severe HTG in pediatric new-onset T1D is rare but presents with variable clinical manifestations.
  • Cases were associated with high-risk complications, including acute pancreatitis.
  • The true incidence and long-term sequelae require further investigation.

Conclusions:

  • Severe HTG in pediatric new-onset T1D, though rare, necessitates clinical attention due to potential complications.
  • Early screening for HTG and pancreatitis is suggested for pediatric patients with new-onset T1D and prolonged abdominal pain.
  • Close monitoring of pediatric patients identified with significant HTG is recommended.

Keywords:
hypertriglyceridemialipidnew-onset diabetespediatrictype 1 diabetes

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
265
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
702
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
408